Restoration of Reaching and Grasping Function in Individuals with Spinal Cord Injury Using MyndMove® Neuromodulation Therapy
The goal of this trial is to determine if a non-invasive muscle stimulation therapy is as good as or better than standard therapy aimed at improving arm and hand function following a cervical spinal cord injury (SCI).
About This Study
The study will compare electrical neuromodulation delivered by MyndMove® therapy to intensive upper-limb conventional therapy in the treatment of individuals with moderate to severe motor impairment to their arms and hands from an incomplete, traumatic SCI.
To compare the efficacy of MyndMove® therapy vs intensive conventional therapy in improving upper extremity function the study will utilize standard outcome measure testing.
- Spinal Cord Independence Measure self-care sub score (SCIM-SC)
- Graded Refined Assessment of Strength Sensibility and Prehension (GRASSP)
- Toronto Rehab Institute Hand Function Test (TRI-HFT)
- Spinal Cord Injury-Quality of Life (SCI-QOL)
Detailed program information and criteria available at: https://clinicaltrials.gov/ct2/show/NCT03439319?term=NCT03439319&draw=2&rank=1
Principal Investigators: Kimberly Anderson, PhD
Program Contact: Kimberly Mackay, LPN
Contact Number: (216) 957-3558
Contact Email: email@example.com
Researchers rely on individuals to serve as volunteers for program studies. Each study is designed to answer questions about a specific medical aspect or the effectiveness of a particular treatment. Through the commitment of research volunteers, knowledge gained and communicated to other medical professionals ultimately benefits the community.
If you would like more information about becoming a research volunteer please submit the information below.